Dual-Targeting Nanoparticles for In Vivo Delivery of Suicide Genes to Chemotherapy-Resistant Ovarian Cancer Cells-Reference-Cited by-同舟云学术

Dual-Targeting Nanoparticles for In Vivo Delivery of Suicide Genes to Chemotherapy-Resistant Ovarian Cancer Cells

Published:2016-12-12 Issue:2 Volume:16 Page:323-333
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Cocco Emiliano,Deng Yang,Shapiro Erik M.,Bortolomai Ileana,Lopez Salvatore,Lin Ken,Bellone Stefania,Cui Jiajia,Menderes Gulden,Black Jonathan D.,Schwab Carlton L.,Bonazzoli Elena,Yang Fan,Predolini Federica,Zammataro Luca,Altwerger Gary,de Haydu Christopher,Clark Mitchell,Alvarenga Julio,Ratner Elena,Azodi Masoud,Silasi Dan-Arin,Schwartz Peter E.,Litkouhi Babak,Saltzman W. Mark,Santin Alessandro D.

Funder

NIH

The Italian Ministry of Health

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of emerging technologies to enhance the treatment of ovarian cancer;Pharmaceutical Development and Technology;2023-07-19

2. Association of CDKN2A/B mutations, PD-1, and PD-L1 with the risk of acute lymphoblastic leukemia in children;Journal of Cancer Research and Clinical Oncology;2023-06-14

3. Suicide gene strategies applied in ovarian cancer studies;Cancer Gene Therapy;2023-01-30

4. The role and mechanism of claudins in cancer;Frontiers in Oncology;2022-12-22

5. miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2;Cancer Gene Therapy;2022-12-09